Budget: Pensions to get boost as tax-free limit to rise
Author: admintech | Filed under: BusinessPersuading workers to work longer is part of plans to boost growth, but critics say very few will benefit.
» Read the rest of this entryPersuading workers to work longer is part of plans to boost growth, but critics say very few will benefit.
» Read the rest of this entryFears remain over the fallout from the demise of the US bank and the future of interest rate rises.
» Read the rest of this entryThe number of jobs on offer drops as the chancellor prepares to set out plans to get people back to work.
» Read the rest of this entryThere are 10m people out of work in the UK, so if you’re searching for a job you’re not alone. Here are some tips on how to get started.
» Read the rest of this entryYoung people tell the BBC what help they hope will be announced in the Spring Budget on Wednesday.
» Read the rest of this entryAwarding organization Ethisphere says companies committed to business integrity elevate standards, have better long-term performance NORTH CANTON, Ohio, March 13, 2023 /PRNewswire/ — The Timken Company (NYSE: TKR; www.timken.com), a […]
» Read the rest of this entryBMO is the only bank in Canada to be recognized since the award’s inception in 2007 TORONTO and CHICAGO, March 13, 2023 /PRNewswire/ – BMO has been recognized as one […]
» Read the rest of this entryFourth Quarter Operating Income Increased 167% Year-Over-Year Record Full-Year Operating Income of $77.8 million, Adjusted EBITDA1 of $83.2 million and EPS of $3.26 NEWARK, N.J., March 13, 2023 /PRNewswire/ — […]
» Read the rest of this entryReport highlights progress on key environmental and social initiatives CHICAGO, March 13, 2023 /PRNewswire/ — Conagra Brands, Inc. (NYSE: CAG) today announced the publication of its 2022 Citizenship Report, an […]
» Read the rest of this entryGenprex Chief Manufacturing and Technology Officer to Provide Insight on Manufacturing Gene Therapies AUSTIN, Texas, March 13, 2023 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage […]
» Read the rest of this entry